The animal trials for the much-awaited H1N1 vaccine have been completed by the Pune-based Serum Institute of India (SII). The Institute is hopeful of beginning human clinical trials by December 15.

The firm, which sent a report on the attenuated intranasal spray tests on animals to the Drug Controller General of India (DCGI) on Tuesday, is eyeing a March deadline to bring out the vaccine.